Back
Day Range
$58.74
$65.67
52-Week Range
$26.56
$83.31
Volume
733,538
50D / 200D Avg
$69.74
/
$54.65
Prev Close
$62.65
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -34.2 | 0.4 |
| P/B | 74.2 | 2.9 |
| ROE % | -133.3 | 3.7 |
| Net Margin % | -24.2 | 3.8 |
| Rev Growth 5Y % | 13.6 | 10.0 |
| D/E | 11.2 | 0.2 |
Key Takeaways
Revenue grew 13.61% annually over 5 years — strong growth
Debt/Equity of 11.23 — high leverage
Negative free cash flow of -56.94M
PEG of 0.99 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.53%
Capital efficient — spends only 2.87% of revenue on capex
Growth
Revenue Growth (5Y)
13.61%
Revenue (1Y)27.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-133.25%
ROIC-10.16%
Net Margin-24.19%
Op. Margin-18.48%
Safety
Debt / Equity
11.23
Current Ratio3.04
Interest Coverage-1.54
Valuation
P/E Ratio
-34.23
P/B Ratio74.23
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 27.14% | Revenue Growth (3Y) | 13.05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13.61% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 211.08M | Net Income (TTM) | -51.06M |
| ROE | -133.25% | ROA | -14.30% |
| Gross Margin | 69.32% | Operating Margin | -18.48% |
| Net Margin | -24.19% | Free Cash Flow (TTM) | -56.94M |
| ROIC | -10.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 11.23 | Current Ratio | 3.04 |
| Interest Coverage | -1.54 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -34.23 | P/B Ratio | 74.23 |
| P/S Ratio | 8.28 | PEG Ratio | 0.99 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.75B | Enterprise Value | 1.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 211.08M | 166.03M | 165.15M | 161.70M | 126.68M |
| Net Income | -51.06M | -84.60M | -78.50M | -75.21M | -41.14M |
| EPS (Diluted) | -1.72 | -3.00 | -3.07 | -3.08 | -1.72 |
| Gross Profit | 146.31M | 109.53M | 106.98M | 106.60M | 85.40M |
| Operating Income | -39.01M | -49.99M | -65.03M | -39.66M | -25.14M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 357.17M | 346.83M | 268.64M | 211.06M | 139.53M |
| Total Liabilities | 333.62M | 293.74M | 250.25M | 219.25M | 88.79M |
| Shareholders' Equity | 23.55M | 53.10M | 18.40M | -8.19M | 50.74M |
| Total Debt | 264.47M | 225.29M | 192.22M | 179.35M | 54.21M |
| Cash & Equivalents | 75.57M | 90.35M | 40.04M | 66.36M | 53.42M |
| Current Assets | 249.94M | 243.04M | 174.90M | 149.90M | 113.27M |
| Current Liabilities | 82.14M | 68.28M | 57.15M | 38.96M | 31.89M |